Published in Lancet on August 12, 1995
Sertraline-induced agranulocytosis. Postgrad Med J (1996) 0.75
Osmotic control of glycine betaine biosynthesis and degradation in Rhizobium meliloti. J Bacteriol (1988) 2.64
Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr (2001) 2.38
Dimer formation by an N-terminal coiled coil in the APC protein. Proc Natl Acad Sci U S A (1993) 2.05
Towards unbiased parentage assignment: combining genetic, behavioural and spatial data in a Bayesian framework. Mol Ecol (2006) 2.03
Osmoregulation in Klebsiella pneumoniae: enhancement of anaerobic growth and nitrogen fixation under stress by proline betaine, gamma-butyrobetaine, and other related compounds. Can J Microbiol (1984) 1.93
Inhibition of autophagy abrogates tumour necrosis factor alpha induced apoptosis in human T-lymphoblastic leukaemic cells. Br J Haematol (1997) 1.87
Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy. Br J Cancer (2000) 1.74
Osmoprotection of Escherichia coli by ectoine: uptake and accumulation characteristics. J Bacteriol (1992) 1.72
Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology (1994) 1.65
Durable remissions of myelodysplastic syndrome and acute myeloid leukemia after reduced-intensity allografting. J Clin Oncol (2003) 1.59
Fewer invited talks by women in evolutionary biology symposia. J Evol Biol (2013) 1.58
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology (Oxford) (2006) 1.53
Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care. Anaesthesia (2005) 1.50
Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study. Leukemia (2008) 1.46
G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial. Br J Haematol (1997) 1.42
Is it refractory idiopathic thrombocytopenic purpura? Lancet (1997) 1.39
Treatment of erythropoietin resistance with cyclosporin. Lancet (1994) 1.38
A retrospective study of risk factors of akathisia in terminally ill patients. J Pain Symptom Manage (1994) 1.38
Replication of bacteriophage T7 DNA by purified proteins. Cold Spring Harb Symp Quant Biol (1979) 1.38
High-dose intravenous IgG in adults with autoimmune thrombocytopenia. Lancet (1983) 1.34
Osmoadaptation in rhizobia: ectoine-induced salt tolerance. J Bacteriol (1994) 1.32
Characterization of three choline transport activities in Rhizobium meliloti: modulation by choline and osmotic stress. J Bacteriol (1989) 1.26
Pipecolic acid is an osmoprotectant for Escherichia coli taken up by the general osmoporters ProU and ProP. Microbiology (1994) 1.24
Erythrapheresis in patients with polycythaemia secondary to hypoxic lung disease. Br Med J (Clin Res Ed) (1983) 1.23
CCNU (lomustine), idarubicin and dexamethasone (CIDEX): an effective oral regimen for the treatment of refractory or relapsed myeloma. Br J Haematol (2000) 1.21
Pulmonary aspergillosis in patients with leukaemia. J Clin Pathol (1990) 1.20
Glycine betaine-assisted protein folding in a lysA mutant of Escherichia coli. J Biol Chem (2000) 1.19
Malnutrition in hospitalized pediatric patients. Current prevalence. Arch Pediatr Adolesc Med (1995) 1.18
Intravenous ciprofloxacin in the treatment of infection in immunocompromised patients. J Antimicrob Chemother (1986) 1.17
Evidence that Escherichia coli accumulates glycine betaine from marine sediments. Appl Environ Microbiol (1990) 1.15
Severe aplastic anaemia after parvovirus infection in the absence of underlying haemolytic anaemia. J Clin Pathol (1988) 1.15
T cell receptor gene rearrangements define a monoclonal T cell proliferation in patients with T cell lymphocytosis and cytopenia. Blood (1986) 1.15
Age-related changes in triathlon performances. Int J Sports Med (2010) 1.14
Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells. Blood (2001) 1.13
Transient Accumulation of Glycine Betaine and Dynamics of Endogenous Osmolytes in Salt-Stressed Cultures of Sinorhizobium meliloti. Appl Environ Microbiol (1997) 1.11
Treatment of the Guillain-Barré syndrome by plasma exchange. J Neurol Neurosurg Psychiatry (1982) 1.11
Lymphocyte subsets in subjects exposed to asbestos: changes in circulating natural killer cells. Br J Ind Med (1992) 1.10
Chronic T cell lymphocytosis: a review of 21 cases. Br J Haematol (1984) 1.10
Pathology of the liver in leukaemia and lymphoma. A study of 110 autopsies. Histopathology (1995) 1.08
Experimental evidence for innate predator recognition in the Seychelles warbler. Proc Biol Sci (2000) 1.08
Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. Bone Marrow Transplant (2008) 1.08
Differential Effects of Dimethylsulfoniopropionate, Dimethylsulfonioacetate, and Other S-Methylated Compounds on the Growth of Sinorhizobium meliloti at Low and High Osmolarities. Appl Environ Microbiol (1998) 1.06
Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study. Bone Marrow Transplant (1999) 1.05
Desensitisation to allopurinol. Ann Rheum Dis (1987) 1.05
Neurological deficit associated with Mycoplasma pneumoniae reversed by plasma exchange. Br Med J (Clin Res Ed) (1983) 1.02
Single locus typing of MHC class I and class II B loci in a population of red jungle fowl. Immunogenetics (2008) 1.02
Sucrose is a nonaccumulated osmoprotectant in Sinorhizobium meliloti. J Bacteriol (1998) 1.02
von Willebrand factor release and P-selectin expression is stimulated by thrombin and trypsin but not IL-1 in cultured human endothelial cells. Thromb Haemost (1993) 1.01
Monocyte anergy in septic shock is associated with a predilection to apoptosis and is reversed by granulocyte-macrophage colony-stimulating factor ex vivo. J Infect Dis (1998) 1.01
Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemia/lymphoma during immunosuppressive treatment following renal transplantation. Clin Infect Dis (1995) 1.01
Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML. Bone Marrow Transplant (2008) 1.00
Effects of cell purification methods on CD11b and L-selectin expression as well as the adherence and activation of leucocytes. J Immunol Methods (1995) 1.00
Multiple myeloma and immune thrombocytopenia. Clin Lab Haematol (2000) 1.00
Nanomolar levels of dimethylsulfoniopropionate, dimethylsulfonioacetate, and glycine betaine are sufficient to confer osmoprotection to Escherichia coli. Appl Environ Microbiol (1999) 0.99
Benign monoclonal expansion of CD8+ lymphocytes in HIV infection. J Clin Pathol (2000) 0.98
Bax translocation is crucial for the sensitivity of leukaemic cells to etoposide-induced apoptosis. Oncogene (2001) 0.97
The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study. Intensive Care Med (1994) 0.97
A British National Lymphoma Investigation randomised trial of single agent chlorambucil plus radiotherapy versus radiotherapy alone in low grade, localised non-Hodgkins lymphoma. Med Oncol (1994) 0.94
Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D. Gen Pharmacol (1999) 0.94
Mitochondrial ultracondensation, but not swelling, is involved in TNF alpha-induced apoptosis in human T-lymphoblastic leukaemic cells. Leuk Res (1997) 0.94
Interleukin-3 in hematology and oncology: current state of knowledge and future directions. Cytokines Cell Mol Ther (1999) 0.94
The risk of antimalarials in patients with renal failure. Postgrad Med J (2007) 0.93
Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis. Blood (1999) 0.93
Angiogenesis and angiogenic mediators in haematological malignancies. Br J Haematol (2000) 0.93
Evaluation of habitual physical activity from a week's heart rate monitoring in French school children. Eur J Appl Physiol Occup Physiol (1996) 0.92
Serum immunoreactive erythropoietin in hypoxic lung disease with and without polycythaemia. Clin Sci (Lond) (1985) 0.92
Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma. Hematol J (2000) 0.92
Hyponatraemia as a cause of reversible ataxia. Br Med J (Clin Res Ed) (1986) 0.92
Pancoast's tumour due to aspergilloma. Lancet (1991) 0.91
Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients. Am J Hematol (1993) 0.91
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. Br J Cancer (1999) 0.90
Unusual T cell proliferations and neutropenia in rheumatoid arthritis: comparison with classical Felty's syndrome. Scand J Haematol (1984) 0.90
Combination chemotherapy with conservative obstetric management in the treatment of pregnant patients with acute myeloblastic leukaemia. Clin Lab Haematol (1989) 0.89
Pericardial effusion following conditioning for bone marrow transplantation in acute leukaemia. Bone Marrow Transplant (1987) 0.89
The osmoprotectant glycine betaine inhibits salt-induced cross-tolerance towards lethal treatment in Enterococcus faecalis. Microbiology (1999) 0.89
A base substitution (T-->C) in codon 29 of the alpha 2-globin gene causes alpha thalassaemia. Br J Haematol (1993) 0.88
Autoimmune cytopenias in the 22q11.2 deletion syndrome. Clin Lab Haematol (2003) 0.88
Aplastic anaemia in systemic lupus erythematosus: a cellular immune mechanism? Br J Rheumatol (1991) 0.88
Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985. Haematol Blood Transfus (1987) 0.88
A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease. Br J Cancer (1989) 0.88
Effect of fixation on quantification of the expression of leucocyte function-associated surface antigens. Cytometry (1994) 0.88
A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies. J Antimicrob Chemother (1992) 0.88
The impact of reproductive investment and early-life environmental conditions on senescence: support for the disposable soma hypothesis. J Evol Biol (2013) 0.87
Quantitative determination of apoptosis on leukemia cells by infrared spectroscopy. Apoptosis (2001) 0.87
Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells. J Immunol (1998) 0.87